 |
The Journal of Neuroscience, July 28, 2004, 24(30):6724-6732; doi:10.1523/JNEUROSCI.5520-03.2004
 Previous Article | Next Article 
Development/Plasticity/Repair
Opposing Extracellular Signal-Regulated Kinase and Akt Pathways Control Schwann Cell Myelination
Toru Ogata,1
Satoru Iijima,1,2
Shinya Hoshikawa,1
Toshiki Miura,1
Shin-ichi Yamamoto,1
Hiromi Oda,1
Kozo Nakamura,1 and
Sakae Tanaka1
1Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan, and 2Department of Orthopaedic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
Schwann cells are the myelinating glia of the peripheral nervous system, and their development is regulated by various growth factors, such as neuregulin, platelet-derived growth factor (PDGF), and insulin-like growth factor-I (IGF-I). However, the mechanism of intracellular signaling pathways following these ligand stimuli in Schwann cell differentiation remains elusive. Here, we demonstrate that in cultured Schwann cells, neuregulin and PDGF suppressed the expression of myelin-associated protein markers, whereas IGF-I promoted it. Although these ligands activated common downstream signaling pathways [i.e., extracellular signal-regulated kinase (Erk) and phosphatidylinositol-3-kinase (PI3K)-Akt pathways], the profiles of activation varied among ligands. To elucidate the function of these pathways and the mechanisms underlying Schwann cell differentiation, we used adenoviral vectors to selectively activate or inactivate these pathways. We found that the selective activation of Erk pathways suppressed Schwann cell differentiation, whereas that of PI3K pathways promoted it. Furthermore, lithium chloride, a modulator of glycogen synthase kinase-3 (GSK-3) promoted Schwann cell differentiation, suggesting the involvement of GSK-3 as a downstream molecule of PI3K-Akt pathways. Selective activation of PI3K pathways in Schwann cells by gene transfer also demonstrated increased myelination in in vitro Schwann cell-DRG neuron cocultures and in vivo allogenic nerve graft experiments. We conclude that signals mediated by PI3K-Akt are crucial for initiation of myelination and that the effects of growth factors are primarily dependent on the balance between Erk and PI3K-Akt activation. Our results also propose the possibility of augmenting Schwann cell functions by modulating intracellular signals in light of future cell therapies.
Key words: glia; intracellular; myelin; regeneration; transplantation; peripheral nerve
Received Dec 15, 2003;
revised June 11, 2004;
accepted June 14, 2004.
This article has been cited by other articles:
|
|
|
|
 
J. F. McGuire, S. Rouen, E. Siegfreid, D. E. Wright, and R. T. Dobrowsky
Caveolin-1 and Altered Neuregulin Signaling Contribute to the Pathophysiological Progression of Diabetic Peripheral Neuropathy
Diabetes,
November 1, 2009;
58(11):
2677 - 2686.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Kiguchi, T. Maeda, Y. Kobayashi, Y. Fukazawa, and S. Kishioka
Activation of Extracellular Signal-Regulated Kinase in Sciatic Nerve Contributes to Neuropathic Pain After Partial Sciatic Nerve Ligation in Mice
Anesth. Analg.,
October 1, 2009;
109(4):
1305 - 1311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Mehanna, B. Mishra, N. Kurschat, C. Schulze, S. Bian, G. Loers, A. Irintchev, and M. Schachner
Polysialic acid glycomimetics promote myelination and functional recovery after peripheral nerve injury in mice
Brain,
June 1, 2009;
132(6):
1449 - 1462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Pereira, Y. Benninger, R. Baumann, A. F. Goncalves, M. Ozcelik, T. Thurnherr, N. Tricaud, D. Meijer, R. Fassler, U. Suter, et al.
Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system
J. Cell Biol.,
April 6, 2009;
185(1):
147 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Francis, J. Martinez, W. Liu, T. Nguyen, A. Ayer, J. Fine, D. Zochodne, L. R. Hanson, W. H. Frey II, and C. Toth
Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy
Diabetes,
April 1, 2009;
58(4):
934 - 945.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Freidin, S. Asche, T. A. Bargiello, M. V. L. Bennett, and C. K. Abrams
Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1)
PNAS,
March 3, 2009;
106(9):
3567 - 3572.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Wakatsuki, N. Yumoto, K. Komatsu, T. Araki, and A. Sehara-Fujisawa
Roles of Meltrin-{beta}/ADAM19 in Progression of Schwann Cell Differentiation and Myelination during Sciatic Nerve Regeneration
J. Biol. Chem.,
January 30, 2009;
284(5):
2957 - 2966.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. J. Francis, J. A. Martinez, W. Q. Liu, K. Xu, A. Ayer, J. Fine, U. I. Tuor, G. Glazner, L. R. Hanson, W. H. Frey II, et al.
Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy
Brain,
December 1, 2008;
131(12):
3311 - 3334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Parkinson, A. Bhaskaran, P. Arthur-Farraj, L. A. Noon, A. Woodhoo, A. C. Lloyd, M. L. Feltri, L. Wrabetz, A. Behrens, R. Mirsky, et al.
c-Jun is a negative regulator of myelination
J. Cell Biol.,
October 17, 2008;
181(4):
625 - 637.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. I. Flores, S. P. Narayanan, E. N. Morse, H. E. Shick, X. Yin, G. Kidd, R. L. Avila, D. A. Kirschner, and W. B. Macklin
Constitutively Active Akt Induces Enhanced Myelination in the CNS
J. Neurosci.,
July 9, 2008;
28(28):
7174 - 7183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Mager, R. M. Ward, R. Srinivasan, S.-W. Jang, L. Wrabetz, and J. Svaren
Active Gene Repression by the Egr2{middle dot}NAB Complex during Peripheral Nerve Myelination
J. Biol. Chem.,
June 27, 2008;
283(26):
18187 - 18197.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nadra, A.-S. d. P. Charles, J.-J. Medard, W. T. Hendriks, G.-S. Han, S. Gres, G. M. Carman, J.-S. Saulnier-Blache, M. H.G. Verheijen, and R. Chrast
Phosphatidic acid mediates demyelination in Lpin1 mutant mice
Genes & Dev.,
June 15, 2008;
22(12):
1647 - 1661.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ciarmatori, D. Kiepe, A. Haarmann, U. Huegel, and B. Tonshoff
Signaling mechanisms leading to regulation of proliferation and differentiation of the mesenchymal chondrogenic cell line RCJ3.1C5.18 in response to IGF-I
J. Mol. Endocrinol.,
April 1, 2007;
38(4):
493 - 508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. LeBlanc, S.-W. Jang, R. M. Ward, L. Wrabetz, and J. Svaren
Direct Regulation of Myelin Protein Zero Expression by the Egr2 Transactivator
J. Biol. Chem.,
March 3, 2006;
281(9):
5453 - 5460.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-M. Yu, M. L. Feltri, L. Wrabetz, S. Strickland, and Z.-L. Chen
Schwann Cell-Specific Ablation of Laminin {gamma}1 Causes Apoptosis and Prevents Proliferation
J. Neurosci.,
May 4, 2005;
25(18):
4463 - 4472.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. T. Dobrowsky, S. Rouen, and C. Yu
Altered Neurotrophism in Diabetic Neuropathy: Spelunking the Caves of Peripheral Nerve
J. Pharmacol. Exp. Ther.,
May 1, 2005;
313(2):
485 - 491.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Guertin, D. P. Zhang, K. S. Mak, J. A. Alberta, and H. A. Kim
Microanatomy of Axon/Glial Signaling during Wallerian Degeneration
J. Neurosci.,
March 30, 2005;
25(13):
3478 - 3487.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
